Shunda Du

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0002-9357-3259

发表论文 220 篇 · 总被引 2802 次 · h-index 26

代表论文

• Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial (2025 · Gut · 被引 14)
• Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models (2025 · Molecular Cancer · 被引 11)
• Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetes (2025 · Atherosclerosis · 被引 5)
• Urinary biomarkers in cancer detection: explorations, advancements, challenges, and future directions (2025 · International Journal of Surgery · 被引 4)
• Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study (2025 · Journal of Hepatocellular Carcinoma · 被引 4)
• A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors (2025 · Scientific Data · 被引 3)